SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0000950103-19-002292
Filing Date
2019-02-25
Accepted
2019-02-25 14:00:54
Documents
4
Group Members
022019 MERGER SUBSIDIARY, INC.

Document Format Files

Seq Description Document Type Size
1 FORM SC TO-C dp102644_sctoc.htm SC TO-C 20240
2 EXHIBIT 99.1 dp102644_ex9901.htm EX-99.1 23763
3 EXHIBIT 99.2 dp102644_ex9902.htm EX-99.2 75784
4 GRAPHIC image_001.jpg GRAPHIC 1805
  Complete submission text file 0000950103-19-002292.txt   124083
Mailing Address 1 DNA WAY, MS #24, SOUTH SAN FRANCISCO CA 94080
Business Address C/O THE CORPORATION TRUST, 1209 ORANGE STREET, WILMINGTON, DE 19801 650 225-7893
ROCHE HOLDINGS INC (Filed by) CIK: 0000904566 (see all company filings)

IRS No.: 510304944 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 0000

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Subject) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-88577 | Film No.: 19628897
SIC: 2836 Biological Products, (No Diagnostic Substances)